Skip to main content
. 2017 Jan 10;8(7):12186–12193. doi: 10.18632/oncotarget.14575

Figure 3. Kaplan-Meier analysis of overall survival based on FSIP1 status in 202 NSCLC patients.

Figure 3

The 5-year overall survival rate in the FSIP1-positive group was lower than that in FSIP1-negative group (p<0.001).